Pyrazole-Thiazole Core-Containing Analogs Exhibit Adjunctive Activity with Meropenem against Carbapenem-Resistant Enterobacteriaceae (CRE)

被引:3
|
作者
Kim, Chungsik [1 ]
Kassu, Mintesinot [1 ]
Smith, Kenneth P. [3 ]
Kirby, James E. [3 ]
Manetsch, Roman [1 ,2 ]
机构
[1] Northeastern Univ, Dept Chem & Chem Biol, 360 Huntington Ave, Boston, MA 02115 USA
[2] Northeastern Univ, Dept Pharmaceut Sci, 360 Huntington Ave, Boston, MA 02115 USA
[3] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
antibacterial activity; carbapenem-resistant enterobacteriaceae; adjunctive activity; meropenem; GRAM-NEGATIVE BACTERIA; BLOOD-STREAM; INFECTIONS; DESIGN; COMBINATION; DERIVATIVES; INHIBITORS;
D O I
10.1002/cmdc.202100321
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Pyrazole-thiazole core-containing compound KP-40 and 20 novel derivatives were designed and synthesized through traditional SAR analysis. These molecules displayed adjunctive activity with meropenem against Gram-negative bacteria evidenced by a range of fractional inhibitory concentration (FIC=0.5-0.25) and minimum adjunctive concentration (MAC=128-32 mu M) values. Of this series of molecules, four compounds displayed notable adjunctive potential, with FIC and MAC values of 0.25 and 32 mu M, respectively. Moreover, the solubility of these compounds was improved to an acceptable range. Further analysis using our "in house" permeation and efflux multi parameter optimization (PEMPO) algorithm revealed key physicochemical properties that may be critical for the development of active Gram-negative antibacterials. Taking PEMPO scores into consideration prior to executing synthesis of analogs may be a simple, yet rapid and effective strategy that can be used in conjunction with traditional SAR approaches to aid in the design of potent Gram-negative antibacterials.
引用
收藏
页码:2775 / 2780
页数:6
相关论文
共 50 条
  • [1] ACTIVITY OF MEROPENEM AGAINST IMIPENEM-RESISTANT BACTERIA AND SELECTION INVITRO OF CARBAPENEM-RESISTANT ENTEROBACTERIACEAE
    PIDDOCK, LJV
    TURNER, HL
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1992, 11 (12) : 1186 - 1191
  • [2] Activity of Meropenem-Vaborbactam against Carbapenem-Resistant Enterobacteriaceae in a Murine Model of Pyelonephritis
    Weiss, William J.
    Pulse, Mark E.
    Phung Nguyen
    Peterson, Kelly
    Silva, Jessica
    Simecka, Jerry W.
    Valtierra, David
    Sabet, Mojgan
    Griffith, David C.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (01)
  • [3] Meropenem-vaborbactam: a carbapenem and beta-lactamase inhibitor with activity against carbapenem-resistant Enterobacteriaceae
    Young R. Lee
    Nathaniel T. Baker
    European Journal of Clinical Microbiology & Infectious Diseases, 2018, 37 : 1411 - 1419
  • [4] Meropenem-vaborbactam: a carbapenem and beta-lactamase inhibitor with activity against carbapenem-resistant Enterobacteriaceae
    Lee, Young R.
    Baker, Nathaniel T.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2018, 37 (08) : 1411 - 1419
  • [5] In vitro activity of plazomicin against β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE)
    Zhang, Yunliang
    Kashikar, Ankita
    Bush, Karen
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (10) : 2792 - 2795
  • [6] Meropenem and Vaborbactam: Stepping up the Battle against Carbapenem-resistant Enterobacteriaceae
    Jorgensen, Sarah Christina Jane
    Rybak, Michael Joseph
    PHARMACOTHERAPY, 2018, 38 (04): : 444 - 461
  • [7] Discovery of a Novel Metallo-β-Lactamase Inhibitor That Potentiates Meropenem Activity against Carbapenem-Resistant Enterobacteriaceae
    Everett, Martin
    Sprynski, Nicolas
    Coelho, Alicia
    Castandet, Jerome
    Bayet, Maelle
    Bougnon, Juliette
    Lozano, Clarisse
    Davies, David T.
    Leiris, Simon
    Zalacain, Magdalena
    Morrissey, Ian
    Magnet, Sophie
    Holden, Kirsty
    Warn, Peter
    De Luca, Filomena
    Docquier, Jean-Denis
    Lemonnier, Marc
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (05)
  • [8] Antimicrobial Activity of Lactobacillus Species Against Carbapenem-Resistant Enterobacteriaceae
    Chen, Chi-Chung
    Lai, Chih-Cheng
    Huang, Hui-Ling
    Huang, Wen-Yu
    Toh, Han-Siong
    Weng, Tzu-Chieh
    Chuang, Yin-Ching
    Lu, Ying-Chen
    Tang, Hung-Jen
    FRONTIERS IN MICROBIOLOGY, 2019, 10
  • [9] Effects of KPC Variant and Porin Genotype on the In Vitro Activity of Meropenem-Vaborbactam against Carbapenem-Resistant Enterobacteriaceae
    Wilson, William R.
    Kline, Ellen G.
    Jones, Chelsea E.
    Morder, Kristin T.
    Mettus, Roberta T.
    Doi, Yohei
    Nguyen, M. Hong
    Clancy, Cornelius J.
    Shields, Ryan K.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (03)
  • [10] Carbapenem-Containing Combination Antibiotic Therapy against Carbapenem-Resistant Uropathogenic Enterobacteriaceae
    Loose, Maria
    Link, Isabell
    Naber, Kurt G.
    Wagenlehner, Florian M. E.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (01)